Clinical Trial Update: Immunological Basis for Benralizumab Activity in Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]

View source ↗

Summary

Phase 2 trial investigating the immunological basis for benralizumab activity in chronic obstructive pulmonary disease (COPD).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Benralizumab (benralizumab)

Snippet

Sponsor: Temple University | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Phase 2 | Status: UNKNOWN